drugset / Trial / NCT05095077

Effects of Single Dose Tadalafil on Urethral and Anal Closure Function

NCT05095077

Phase 1 Completed 24 enrolled University Hospital Bispebjerg and Frederiksberg
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the trial is to assess the effect of tadalafil compared to placebo (inactive comparator) on the urethral - and anal pressure and on urine flow in healthy females. Further, the purpose of the trial is to evaluate the potential for going forward with studies of tadalafil in patients suffering from urine or fecal incontinence.

Timeline

Start
2021-08-01
Primary completion
2021-12-30
Completion
2022-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 40 mg